latest news releases from the newsroom
Streamburst Launches Revolutionary Alternative to Digital Rights Management
LONDON, Jan. 29, 2007 (PRIME NEWSWIRE) -- Streamburst, based in London, announces its Digital Rights Management (DRM) free service -- the way forward for Internet downloading and anti-piracy schemes. Using the Streamburst service enables distribution of high-quality video content over the Internet without the cumbersome restrictions of DRM whilst offering a strong and more practical solution for piracy deterrence and copyright law enforcement.
American Mold Guard Inc.
American Mold Guard Names Robert Bayer Corporate Vice President of Sales
SAN JUAN CAPISTRANO, Calif., Jan. 29, 2007 (PRIME NEWSWIRE) -- American Mold Guard (Nasdaq:AMGI), the industry leader in mold prevention services, announced today that Robert Bayer has joined the Company as Corporate Vice President of Sales. Mr. Bayer will oversee national sales and build upon sales momentum within existing regions. He will also be responsible for the Company's expansion in key regions in the Pacific Northwest, Southeast and Northeast that is planned for early this year.
The Plasencia Group
The Plasencia Group, Inc. Names Russ C. Valentine as Senior Vice President of Its Mid-Atlantic Region
TAMPA, Fla., Jan. 29, 2007 (PRIME NEWSWIRE) -- The Plasencia Group, Inc. (TPG), the leading national hospitality transaction and consulting services firm representing owners of hotels, resorts, and golf courses, has appointed Russ C. Valentine as Senior Vice President of the firm's Mid-Atlantic Region. Mr. Valentine is based in Bethesda, MD and will be responsible for transactions in the Virginias, North Carolina, Maryland, lower Pennsylvania and the District of Columbia, according to TPG President Richard Conti.
The NASDAQ OMX Group, Inc.
Delisting of Securities of Taro Pharmaceutical Industries, Ltd. from The NASDAQ Stock Market
NEW YORK, Jan. 29, 2007 (PRIME NEWSWIRE) -- The NASDAQ Stock Market announced today that it will delist the ordinary shares of Taro Pharmaceutical Industries, Ltd. Taro Pharmaceutical's stock was suspended on December 14, 2006 and has not traded on NASDAQ since that time. NASDAQ will file a Form 25 with the Securities and Exchange Commission to complete the delisting. The delisting becomes effective ten days after the Form 25 is filed. For news and additional information about the company, including the basis for the delisting and whether the company's securities are trading on another venue, please review the company's public filings or contact the company directly.
New York Business Group on Health
New York Business Group On Health Convenes Conference On Health Program ROI
NEW YORK, Jan. 29, 2007 (PRIME NEWSWIRE) -- New York Business Group on Health (NYBGH) will present "Trends in Health & Productivity Management: Measuring the ROI of Health Programs" on February 7th, the first of two conferences on health and productivity management. The conference will cover important topics for mid- and large-sized businesses, including developing evaluation standards for disease management and creating frameworks for total cost impact.
MediciNova Announces Pricing of Common Stock Offering
SAN DIEGO, Jan. 29, 2007 (PRIME NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on NASDAQ (Nasdaq:MNOV) and the Hercules Market of the Osaka Securities Exchange (Code Number: 4875), today announced the pricing of a public offering of 1,000,000 shares of its common stock at an offering price of $12 per share for approximately $11.2 million in proceeds, net of underwriting commissions but before expenses.